Plasma exchange in episodes of severe inflammatory demyelination of the central nervous system - A report of six cases

被引:19
作者
Bennetto, L [1 ]
Totham, A
Healy, P
Massey, E
Scolding, N
机构
[1] Univ Bristol, Frenchay Hosp, Inst Clin Neurosci, Bristol BS16 1LE, Avon, England
[2] Bristol Natl Blood Serv, Bristol BS10 5ND, Avon, England
关键词
plasma exchange; multiple sclerosis; demyelinating diseases; demyelinating autoimmune diseases; CNS;
D O I
10.1007/s00415-004-0588-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The standard therapy for episodes of severe acute inflammatory demyelinating disease of the central nervous system is high dose intravenous corticosteroids. A small proportion of patients fail to improve with this regime and their prognosis can become grave. A recent sham controlled double blind crossover trial in this group of patients demonstrated a significant benefit from plasma exchange. We report six patients with severe acute steroid-insensitive inflammatory demyelinating disease of the central nervous system treated with plasma exchange. We observed a clear improvement in five of these six patients. Whilst complications of plasma exchange occurred these did not outweigh the benefits. Our study supports the use of plasma exchange in severe acute steroid-insensitive inflammatory disease of the central nervous system.
引用
收藏
页码:1515 / 1521
页数:7
相关论文
共 50 条
  • [31] Inflammatory diseases of the central nervous system
    Bachhuber, Armin
    RADIOLOGE, 2021, 61 (06): : 575 - 585
  • [32] Oligodeoxynucleotide IMT504: Effects on Central Nervous System Repair Following Demyelination
    Mathieu, Patricia A.
    Sampertegui, Yim Rodriguez
    Elias, Fernanda
    Silva, Alexis Silva
    Calcagno, Maria de Lujan
    Lopez, Ricardo
    Adamo, Ana M.
    MOLECULAR NEUROBIOLOGY, 2023, 61 (7) : 4146 - 4165
  • [33] Plasma exchange in acute attacks of demyelinating diseases of the central nervous system: clinical outcomes and predictors of response
    Michael A. Palacios-Mendoza
    María L. Martínez Ginés
    Pedro J. Melgarejo Otálora
    Juan P. Cuello
    Antonio Sánchez-Soblechero
    Alberto Lozano Ros
    José A. Aparcero-Suero
    Sergio López Anguita
    Fernando Anaya
    José M. García Domínguez
    Neurological Sciences, 2020, 41 : 2569 - 2574
  • [34] Demyelination in the central nervous system mediated by an anti-oligodendrocyte antibody
    Zhou, LX
    Trapp, BD
    Miller, RH
    JOURNAL OF NEUROSCIENCE RESEARCH, 1998, 54 (02) : 158 - 168
  • [35] Higher fish consumption and lower risk of central nervous system demyelination
    Black, Lucinda J.
    Zhao, Yun
    Peng, Yee Cheng
    Sherriff, Jill L.
    Lucas, Robyn M.
    van der Mei, Ingrid
    Pereira, Gavin
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2020, 74 (05) : 818 - 824
  • [36] Hepatitis B vaccination and central nervous system demyelination: an immunological approach
    Piaggio, E
    Younes, AB
    Desbois, S
    Gout, O
    Tourbah, A
    Lyon-Caen, O
    Liblau, RS
    JOURNAL OF AUTOIMMUNITY, 2005, 24 (01) : 33 - 37
  • [37] A comparative study of experimental mouse models of central nervous system demyelination
    Dumitrascu, O. M.
    Mott, K. R.
    Ghiasi, H.
    GENE THERAPY, 2014, 21 (06) : 599 - 608
  • [38] Anomalies Characteristic of Central Nervous System Demyelination Radiologically Isolated Syndrome
    Lebrun, Christine
    Kantarci, Orhun H.
    Siva, Aksel
    Pelletier, Daniel
    Okuda, Darin T.
    NEUROLOGIC CLINICS, 2018, 36 (01) : 59 - +
  • [39] Biopsy-Supported Tumefactive Demyelination of the Central Nervous System in Children
    Hanumanthe, Seema Bangalore
    Francisco, Carla
    Hart, Janace
    Graves, Jennifer
    Waubant, Emmanuelle
    JOURNAL OF CHILD NEUROLOGY, 2016, 31 (14) : 1528 - 1533
  • [40] Corticosteroids delay remyelination of experimental demyelination in the rodent central nervous system
    Chari, DM
    Zhao, C
    Kotter, MR
    Blakemore, WF
    Franklin, RJM
    JOURNAL OF NEUROSCIENCE RESEARCH, 2006, 83 (04) : 594 - 605